OXA-143, a Novel Carbapenem-Hydrolyzing Class D β-Lactamase in Acinetobacter baumannii
- 1 December 2009
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (12), 5035-5038
- https://doi.org/10.1128/aac.00856-09
Abstract
A carbapenem-resistant Acinetobacter baumannii strain was isolated in Brazil in 2004 in which no known carbapenemase gene was detected by PCR. Cloning experiments, followed by expression in Escherichia coli, gave an E. coli recombinant strain expressing a novel carbapenem-hydrolyzing class D β-lactamase (CHDL). OXA-143 showed 88% amino acid sequence identity with OXA-40, 63% identity with OXA-23, and 52% identity with OXA-58. It hydrolyzed penicillins, oxacillin, meropenem, and imipenem but not expanded-spectrum cephalosporins. The blaOXA-143 gene was located on a ca. 30-kb plasmid. After transformation into reference strain A. baumannii ATCC 19606, it conferred resistance to carbapenems. Analysis of the genetic environment of blaOXA-143 revealed that it was associated with neither insertion sequences nor integron structures. However, it was bracketed by similar replicase-encoding genes at both ends, suggesting acquisition through a homologous recombination process. This study identified a novel class D β-lactamase involved in carbapenem resistance in A. baumannii. This enzyme is the first member of a novel subgroup of CHDLs whose prevalence remains to be determined.Keywords
This publication has 26 references indexed in Scilit:
- Carbapenem-Resistant Acinetobacter baumannii Isolates from Tunisia Producing the OXA-58-Like Carbapenem-Hydrolyzing Oxacillinase OXA-97Antimicrobial Agents and Chemotherapy, 2008
- Acinetobacter radioresistensas a Silent Source of Carbapenem Resistance forAcinetobactersppAntimicrobial Agents and Chemotherapy, 2008
- OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumanniiClinical Microbiology & Infection, 2008
- Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TUClinical Microbiology & Infection, 2007
- An increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNature Reviews Microbiology, 2007
- Multiplex PCR for rapid detection of genes encoding acquired metallo- -lactamasesJournal of Antimicrobial Chemotherapy, 2006
- Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiologyClinical Microbiology & Infection, 2006
- The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumanniiFEMS Microbiology Letters, 2006
- Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.International Journal of Antimicrobial Agents, 2006